Study: Brunvoll 2022, BMJ
Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial
Citation
Brunvoll SH, Nygaard AB, Ellingjord-Dale M, Holland P et al (2022). BMJ. PubMed id 36215222.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Cod liver oil: vitamin D, vitamin A and colds Tier B moderate
B 34,601 adults aged 18 to 75 in Norway not taking daily vitamin D (n=34,601)
Quadruple-blind randomised placebo-controlled trial: 5 mL a day of cod liver oil (10 micrograms vitamin D) or placebo for up to six months in winter.
Cod liver oil did not reduce the risk of SARS-CoV-2 infection, serious covid-19, or other acute respiratory infections (for example any acute respiratory infection, relative risk 1.04, 95% CI 0.97 to 1.11). Only low-grade side effects were reported.
As recorded in this card: Brunvoll SH, Nygaard AB, Ellingjord-Dale M, Holland P et al (2022), BMJ, [primary]
Note: Norwegian adults, mostly white; cod liver oil at a low vitamin D dose, so it does not test higher doses or people with dark skin.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.